Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...

The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

Regulatory News: Zydus Lifesciences Limited2 ("Zydus"), a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical’s ...

Zydus will file a mandatory cash tender offer for the remaining shares of Amplitude at the same purchase price of €6.25 per ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

The purchase price is €6.25 per share of equity, putting the transaction value at €256.8 million for the 85.6% stake.

PAI Partners has entered exclusive talks to sell majority stake in Amplitude Surgical, a European medical technology business, alongside the company’s management team and two minority shareholders.

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Amplitude Surgical has experienced significant growth over the last four years, driven by new product development, ...